278 related articles for article (PubMed ID: 33287507)
41. [Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation].
Jiang Y; Su G; Yu W; Li J; Lu Q; Li Y; Zhang W
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):823-6. PubMed ID: 26887511
[TBL] [Abstract][Full Text] [Related]
42. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
[TBL] [Abstract][Full Text] [Related]
43. Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 cases.
Almutairi F; Xu B
Pathol Res Pract; 2024 Feb; 254():155127. PubMed ID: 38241777
[TBL] [Abstract][Full Text] [Related]
44. Caspase 3 as a Novel Marker to Distinguish Chromophobe Renal Cell Carcinoma from Oncocytoma.
Kowalewski A; Szylberg Ł; Tyloch J; Antosik P; Neska-Długosz I; Frąckowski Ł; Tyloch D; Purpurowicz P; Grzanka D
Pathol Oncol Res; 2019 Oct; 25(4):1519-1524. PubMed ID: 30467700
[TBL] [Abstract][Full Text] [Related]
45. [Clinical features on chromophobe renal cell carcinoma].
Wang ZH; DU LH; Hu ZQ; Chen XG; Zhao X; Wang SG; Zhuang QY; Ye ZQ
Zhonghua Wai Ke Za Zhi; 2011 Apr; 49(4):320-3. PubMed ID: 21612697
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma.
Kuroda N; Kanomata N; Yamaguchi T; Imamura Y; Ohe C; Sakaida N; Hes O; Michal M; Shuin T; Lee GH
Med Mol Morphol; 2011 Jun; 44(2):111-5. PubMed ID: 21717314
[TBL] [Abstract][Full Text] [Related]
47. [Renal cell carcinoma in patients with end-stage renal disease: a clinicopathological analysis].
He B; Zhang W; Liu LN; Wang H; Zou YW; Jiang YX; Yu WJ; Shi HL; Liu Y; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):846-850. PubMed ID: 31775432
[No Abstract] [Full Text] [Related]
48. Role Of Immunohistochemistry In Subtyping Renal Cell Carcinomas With Overlapping Morphological Features.
Tariq N; Mamoon N; Haroon A; Ali Z; Ahmad IN
J Ayub Med Coll Abbottabad; 2018; 30(3):325-332. PubMed ID: 30465359
[TBL] [Abstract][Full Text] [Related]
49. Adult renal cell carcinoma with rhabdoid differentiation: incidence and clinicopathologic features in Chinese patients.
Yang X; Xi C; Jin J; Zhou L; Su J; Liu L; Liu Y
Ann Diagn Pathol; 2015 Apr; 19(2):57-63. PubMed ID: 25708024
[TBL] [Abstract][Full Text] [Related]
50. [Clinicopathologic study of renal cell carcinoma with rhabdoid features].
Ma J; Zhou XJ; Huang WB; Zhou HB; Jiang SJ; Rao Q; Lu ZF; Shi QL
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):166-70. PubMed ID: 17535682
[TBL] [Abstract][Full Text] [Related]
51. [Clinicopathological features and diagnosis of pericytic tumors of the kidney].
He YL; Zou YW; Hu YJ; Wu J; Zhang W; Yu WJ; Li YJ; Jiang YX
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):987-992. PubMed ID: 36207911
[No Abstract] [Full Text] [Related]
52. [Sinonasal renal cell-like adenocarcinoma: a clinicopathological analysis of five cases].
Yuan CC; Zhai CW; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1147-1151. PubMed ID: 33152820
[No Abstract] [Full Text] [Related]
53. Diagnostic utility of amylase α-1A, MOC 31, and
Abouhashem NS; Abdelbary EH; H Abdalla MM; El-Shazly M
Indian J Pathol Microbiol; 2020; 63(3):405-411. PubMed ID: 32769329
[TBL] [Abstract][Full Text] [Related]
54. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
55. [Eosinophilic vacuolated tumor of the kidney: clinicopathological and molecular characteristics].
Zhang HZ; Xia QY; Yin XG; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):437-443. PubMed ID: 35511640
[No Abstract] [Full Text] [Related]
56. Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors.
Kuroda N; Tanaka A; Yamaguchi T; Kasahara K; Naruse K; Yamada Y; Hatanaka K; Shinohara N; Nagashima Y; Mikami S; Oya M; Hamashima T; Michal M; Hes O
Med Mol Morphol; 2013 Mar; 46(1):49-55. PubMed ID: 23338778
[TBL] [Abstract][Full Text] [Related]
57. A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma.
Ng KL; Morais C; Bernard A; Saunders N; Samaratunga H; Gobe G; Wood S
J Clin Pathol; 2016 Aug; 69(8):661-71. PubMed ID: 26951082
[TBL] [Abstract][Full Text] [Related]
58. [Immunohistochemical profile of renal cell tumours].
Gutiérrez Olivares VM; González Torres LM; Hunter Cuartas G; Niebles De la Hoz MC
Rev Esp Patol; 2019; 52(4):214-221. PubMed ID: 31530404
[TBL] [Abstract][Full Text] [Related]
59. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
[TBL] [Abstract][Full Text] [Related]
60. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
